Synergy Pharmaceuticals, Inc. - Warrants
SGYPW
SGYPW was delisted on the 6th of December, 2016.
4 hedge funds and large institutions have $595K invested in Synergy Pharmaceuticals, Inc. - Warrants in 2015 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
46% more call options, than puts
Call options by funds: $1.81M | Put options by funds: $1.24M
20% less funds holding
Funds holding: 5 → 4 (-1)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
51% less capital invested
Capital invested by funds: $1.2M → $595K (-$609K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$461 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CI
Cowen Inc
New York
|
-$139K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$19K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $486K | -$19K | -5,400 | -2% |
|
|
CI
2
Cowen Inc
New York
| $73K | -$139K | -39,341 | -32% |
|
3
Twin Tree Management
Dallas,
Texas
| $34K | – | – | – |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $2K | +$461 | +131 | +10% |
|
|
5
UBS Group
Zurich,
Switzerland
| – | -$9K | -2,313 | Closed |
|
SGYPW Hedge Fund Activity: Q3 2015 in Review
4 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Synergy Pharmaceuticals, Inc. - Warrants (SGYPW) for Q3 2015, worth a combined $595K — down 51% from $1.2M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of SGYPW and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 1 added.
The largest buyer was Tower Research Capital (TRC), adding an estimated $461. The largest seller was Cowen Inc, cutting an estimated $139K.
- 4 institutional investors held Synergy Pharmaceuticals, Inc. - Warrants (SGYPW) as of Q3 2015, down from 5 in Q2 2015.
- Funds reported $595K of Synergy Pharmaceuticals, Inc. - Warrants stock for Q3 2015, down 51% quarter-over-quarter.
- 0 funds opened new Synergy Pharmaceuticals, Inc. - Warrants positions in Q3 2015 and 1 closed out, a net change of -1 holder.
- The largest Synergy Pharmaceuticals, Inc. - Warrants buyer in Q3 2015 was Tower Research Capital (TRC), an estimated $461 added.
- The largest Synergy Pharmaceuticals, Inc. - Warrants seller in Q3 2015 was Cowen Inc, an estimated $139K sold.
Based on aggregated 13F filings for Q3 2015.